Skip to content
Menu
Ivermectin in Africa
  • About
  • Contact
  • Forum
  • I-MASK+ Protocol
  • MATH+ Protocol
  • Zimbabwe SID Protocol
Ivermectin in Africa

South African National Department of Health recommends Ivermectin for further clinical trials

Posted on December 22, 2020

In a “rapid review” of Ivermectin for Covid-19 the South African National Department of Health recommended that eligible patients with Covid‐19 in South Africa should be considered for enrolment in relevant therapeutic trials, but did not endorse the drug for general treatment of Covid-19 patients.

“The evidence of efficacy and safety is very uncertain at this point. Early phase studies were of very low quality and do not demonstrate any clear evidence of efficacy or safety,” the committee wrote.

“Eligible patients with COVID‐19 in South Africa should be considered for enrolment in relevant therapeutic trials.”

Read the full report here

Rapid-review-of-Ivermectin-for-COVID-19_21December2020-1Download

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About This Site

Learn more about Ivermectin use for the prophylaxis and treatment of Covid-19. Learn about its history and how it may become a key therapy to fight the current Covid-19 pandemic.

This blog is maintained by Dr Martin Gill, an ENT specialist based in Johannesburg, South Africa.

Categories

  • Africa
  • Experimental
  • In the Media
  • Resources
  • Uncategorized
  • Webinar
  • World

South Africa Covid-19 Update

Recent Comments

  • G on Zimbabwe SID Protocol
  • Ben on Zimbabwe SID Protocol
  • Gillian on Zimbabwe SID Protocol
  • Dr. Glynn Goedhart on Zimbabwe SID Protocol
  • Donna Scholtz on Zimbabwe SID Protocol
©2023 Ivermectin in Africa | WordPress Theme: EcoCoded